Note 9 - Accrued Expenses

9 Months Ended

Sep. 30, 2020

Notes to Financial Statements

Accounts Payable and Accrued Liabilities Disclosure [Text Block]

9. Accrued Expenses

Accrued expenses consist of the following:

	September 30, 2020		December 31, 2019
Compensation and related expenses	$	6,559	$	5,830
Professional fees		2,358		3,850
Operating lease liability - current		1,463		1,141
Clinical trial costs		910		788
Current portion of acquisition-related contingent consideration (Note 4)		11,855		-
Finance lease liability - current		163		-
Other		1,031		836
Total	$	24,339	$	12,445